SOGUG
Showing 1 - 25 of 25
Description of Population With Genitourinary Tumors and COVID-19
Active, not recruiting
- Covid19
- Genito Urinary Cancer
-
Hospitalet de Llobregat, Barcelona, Spain
- +31 more
Sep 21, 2021
Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)
Completed
- Advanced Renal Cell Carcinoma
- Pazopanib + interferon alpha 2A
-
Hospitalet de Llobregat, Barcelona, Spain
- +12 more
Mar 9, 2022
Prostate Cancer Metastatic Trial in Spain (Olaparib)
Active, not recruiting
- Prostate Cancer Metastatic
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Feb 8, 2022
Old Age; Debility, Renal Carcinoma Metastatic Trial in Spain (Cabozantinib)
Recruiting
- Old Age; Debility
- Renal Carcinoma Metastatic
-
Ciudad Real, Spain
- +9 more
Feb 8, 2022
Invasive Bladder Cancer Trial in Spain (Durvalumab, Tremelimumab, Radiotherapy)
Active, not recruiting
- Invasive Bladder Cancer
- Durvalumab
- +2 more
-
Badalona, Barcelona, Spain
- +6 more
Mar 9, 2022
Prostate Cancer Stage III, Prostate Cancer Stage IV Trial (drug, biological, radiation)
Active, not recruiting
- Prostate Cancer Stage III
- Prostate Cancer Stage IV
- Docetaxel
- +2 more
- (no location specified)
Jan 20, 2021
Locally Advanced or Metastatic Urothelial Carcinoma Trial in Spain (Atezolizumab 1200 mg/m2, Gemcitabine 1000 mg/m2, Cisplatin
Active, not recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Atezolizumab 1200 mg/m2
- +2 more
-
Barcelona, Spain
- +11 more
Mar 24, 2022
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)
Not yet recruiting
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Enzalutamide 40 MG
- Docetaxel injection
- (no location specified)
Jan 27, 2023
Clear Cell Renal Carcinoma Trial in Spain (Sunitinib)
Completed
- Clear Cell Renal Carcinoma
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +8 more
Nov 12, 2020
Metastatic Prostate Cancer Trial in Spain (docetaxel 75 mg/m2 + prednisone 10 mg/d + abiraterone 1000 mg/d, docetaxel 75 mg/m2 +
Completed
- Metastatic Prostate Cancer
- docetaxel 75 mg/m2 + prednisone 10 mg/d + abiraterone 1000 mg/d
- docetaxel 75 mg/m2 + prednisone 10 mg/d
-
Oviedo, Asturias, Spain
- +16 more
Nov 12, 2020
Bladder Cancer Trial in Spain (Atezolizumab Injection [Tecentriq], External Beam Radiation Therapy (EBRT))
Active, not recruiting
- Bladder Cancer
- Atezolizumab Injection [Tecentriq]
- External Beam Radiation Therapy (EBRT)
-
Manresa, Barcelona, Spain
- +9 more
Oct 25, 2022
Metastatic Hormone-sensitive Prostate Cancer Trial in Spain (Ipilimumab 5 MG/ML, Nivolumab 10 MG/ML, Docetaxel)
Active, not recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- Ipilimumab 5 MG/ML
- +3 more
-
Oviedo, Asturias, Spain
- +29 more
Sep 21, 2021
Carcinoma, Transitional Cell Trial in Spain (Vinflunine, Undefined (standard care))
Completed
- Carcinoma, Transitional Cell
- Vinflunine
- Undefined (standard care)
-
Elda, Alicante, Spain
- +19 more
Apr 2, 2019
International Metastatic Renal Cell Carcinoma Database
Completed
- Metastatic Renal Cell Carcinoma
-
Elche, Alicante, Spain
- +56 more
Apr 25, 2018
Penile Squamous Cell Carcinoma Stage IV Trial in Spain (Pazopanib, Paclitaxel)
Terminated
- Penile Squamous Cell Carcinoma Stage IV
-
Hospitalet de Llobregat, Barcelona, Spain
- +7 more
Oct 13, 2016
Hormone Refractory Prostate Cancer Trial in Spain (Cabazitaxel 10 mg/m2)
Completed
- Hormone Refractory Prostate Cancer
- Cabazitaxel 10 mg/m2
-
Santiago de Compostela, A Coruña, Spain
- +11 more
Jun 29, 2017
Adrenocortical Carcinoma Trial in Spain (Dovitinib)
Completed
- Adrenocortical Carcinoma
-
Santiago de Compostela, A Coruña, Spain
- +6 more
Apr 24, 2017
Carcinoma, Renal Cell Trial in Spain (Gemcitabine, Capecitabine and Sorafenib (6 cycles))
Completed
- Carcinoma, Renal Cell
- Gemcitabine, Capecitabine and Sorafenib (6 cycles)
-
Barcelona, Spain
- +9 more
Jan 13, 2009